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Unusual presentation of a disseminated oral HPV infection 
after combined antiretroviral therapy initiation
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ABSTRACT 
HPV clinical manifestations have their characteristics modified by the use of combined 
antiretroviral therapy (cART), although its incidence is unaffected by cART. We report an 
unusual presentation of oral HPV infection and discuss an effective treatment for disseminated 
HPV lesions. A 52-year-old male of Asian-origin, HIV-seropositive, presented with extensive 
nodular lesions throughout the oral mucosa extending to   the oropharyngeal region. Biopsy 
followed by histopathological examination and HPV genotyping were performed. The 
treatment was initiated with topical application of podophyllin and trichloroacetic acid. HPV 
lesions in oral mucosa are generally easy to handle. Extensive lesions can make it difficult 
to choose an effective treatment that meets the patient’s particularities and medication 
availability.  
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INTRODUCTION
Combined antiretroviral therapy (cART) has increased life expectancy and 
reduced the incidence of most opportunistic infections in patients infected by the 
human immunodeficiency virus (HIV). Although human papillomaviruses (HPV) 
clinical manifestations can have their characteristics modified, their incidence is 
not affected by cART1. 
HPV is involved in a variety of oral lesions as common warts, condyloma 
acuminata, squamous cells papilloma and focal epithelial hyperplasia. All these 
presentations are benign, asymptomatic, exophytic, slow grown lesions2,3. 
Cytodestructive and excisional methods or their combination have been the most 
common choices for a low-cost treatment of lesions caused by HPV4,5. The first 
option of treatment for HPV oral lesions is almost always their surgical removal. 
CASE REPORT
A 52-year-old male of Asian-origin was referred for the diagnosis of multiple 
lesions in the oral cavity. The patient reported to be HIV-seropositive for 12 years, 
during which he did not follow the antiretroviral treatment adequately as he took 
medications on an intermittent basis. When the oral lesions first appeared, T CD4+ 
was 70 cells/mm3, and the patient changed his behaviour and adhered to the 
proposed treatment (Lamivudine, Tenofovir and Atazanavir). Four months after 
cART was initiated, the patient had significant improvement in the immune system 
Vale et al.
Rev Inst Med Trop São Paulo. 2019;61:e54Page 2 of 4
and an increase in T CD4+ to 486 cells/mm3 together with 
undetectable viral load. Concomitantly, the patient observed 
an marked increase in the amount and size of the oral 
lesions, which began to be aesthetically and functionally 
inconvenient, even for daily routine activities, such as 
mastication. After four years living with the increase in the 
amount of oral mucosa lesions, the patient sought treatment.
The intraoral clinical examination detected extensive 
nodular lesions on the entire oral mucosa (i.e. palate, 
tongue, mouth floor, and alveolar, jugal and labial mucosa), 
extending to the oropharyngeal region. The lesions were 
asymptomatic, whitish and erythematous. The majority of 
the lesions, like those seen in the palate and tongue, were 
sessile and had a smooth surface, whereas the others were 
pedunculated and had papillary projections (Figures 1, 2 
and 3).
Incisional biopsy was performed and the material 
obtained was sent for histopathological examination. The 
sections were stained with hematoxylin and eosin, revealing 
a mucosal fragment covered with parakeratinised stratified 
squamous epithelium and acanthosis areas forming either 
blunt or sharp projections, giving a papillomatous aspect to 
the epithelium. At higher magnification, one could observe 
the formation of micro-abscesses, clusters of neutrophils 
and diffuse presence of koilocyte-like cells (Figure 4). In 
addition, a tissue sample was submitted to DNA extraction 
and analyzed by  INNO-Lipa HPV genotyping extra II test 
(INNO-Lipa Innogenetics N.V., Ghent, Belgium), as well 
as PCR sequencing with generic primers, revealing the 
presence of HPV-32. 
Based on the clinical aspect of the lesions, 
histopathological findings and detection of HPV-32, it was 
possible to diagnose the presence of epithelial proliferation 
due to HPV infection. The unusual clinical presentation 
raised discussion on the lesions, suggesting that it might be 
Figure 3 - View of flat lesions with smooth surface on the lower 
labial mucosa, gingival sulcus.
Figure 2 - View of the bilateral jugal mucosa and the soft 
palate showing multiple sessile nodules and some projections, 
resulting in a cobblestone appearance. In the hard palate, one 
can observe some reddish papillomatous lesions. 
Figure 1 - View of the lateral edge and the dorsum of the tongue 
showing pedunculated nodules with smooth surface and lighter 
color than the mucosa.
Figure 4 - Histopathological examination of the lesion 
showing epithelial proliferation forming projections towards 
the connective tissue. In detail, epithelial cells showing a clear 
perinuclear halo compatible with koilocytosis. 
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a case of either focal epithelial hyperplasia (FEH), a lesion 
strongly associated with HPV-324,or condyloma acuminata 
aggravated by the syndrome of immune reconstitution 
(SIR). 
Due to the extension of lesions in the patient and, 
consequently, the great number of surgical procedures that 
would be necessary, as well as  the high viral infectivity 
rate (leading to the possibility of re-contamination of the 
mucosa during manipulation), treatment based on surgical 
removal was discarded. The treatment was initiated with 
topical application of podophyllin and trichloroacetic 
acid6,7. Nevertheless, the long-term treatment unfortunately 
made adhesion difficult for the patient, who did not attend 
the appointments after some sessions.
DISCUSSION
Focal epithelial hyperplasia and oral condyloma 
acuminata have similar clinical and histopathological 
characteristics. Both are caused by low-risk HPVs, with 
condyloma being more often associated with HPV-6 and 
HPV-11, although several other types (including HPV-32 
and more rarely high-risk HPVs) have been described in 
these  lesions4,8,9.  
The syndrome of immune reconstitution (SIR) is a 
significant clinical complication in HIV-infected patients, 
whose immune system improve quickly. Its paradoxical 
form is related to previously-treated opportunistic infections 
re-emerging after immune reconstitution resulting from 
antiretroviral therapy. The unmasking form occurs when an 
underlying or untreated opportunistic infection induces the 
recovering immune system to react against these pathogens. 
The exact mechanism leading to the syndrome of immune 
reconstitution is not yet clear, but some important factors 
are related to its emergence, such as the rapid immune 
recovery after initiating cART and/or rapid decline in 
viral load. In addition to these factors, the diagnosis is 
also based on the relationship between the beginning of 
antiretroviral therapy, the emergence of the disease (within 
about 3 months) and the clinical course of the opportunistic 
infection10.
Based on these concepts, it is possible to speculate that 
the present case may be related to SIR, as the patient had 
a remarkable improvement in the immune response four 
months after cART in view of the clinical picture of unusual 
lesions caused by HPV.
There is no consensus in the literature regarding the 
treatment of extensive lesions as those reported here. 
However, because the viral load of HPV is much higher 
in patients with HPV-32 and multiple oral lesions11, it is 
natural to think that the use of medications acting locally 
and systemically would be the best option in case of viral 
proliferation. Anti-mitotic (e.g. cidofovir) and immune-
modulating agents (e.g. imiquimod, interferon and 
cyclophosphamide)6  have been used with good results. 
Treatment with these medications were discarded because 
of their high cost and the lack of consistent evidence-based 
recommendations.
HPV lesions in oral mucosa have low incidence and are 
generally easy to handle, with surgical excision being the 
treatment of choice. When these lesions affect a patient who 
has immunological deficiencies, one should intervene as 
soon as possible to prevent them from becoming extensive, 
making it difficult to choose an effective treatment. On the 
other hand, it is important to emphasize that the treatment 
should be chosen based on the patient’s particularities 
(e.g. likelihood to adhere to treatment) and availability 
of medications. In addition to the accurate diagnosis, it is 
important to investigate the sub-type of HPV present in 
the patient for the prognosis and management of lesions. 
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